Diethylcarbamazine warnings and precautions

Revision as of 02:13, 7 January 2014 by Gerald Chi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Diethylcarbamazine
HETRAZAN® WHO Prescribing Information
Description
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Warnings and Precautions

Dosage should be reduced in patients with renal impairment.

Patients who are severely ill with other acute diseases should not receive diethylcarbamazine until after their recovery.

Pregnant women should not be treated until after delivery.[1]

References

  1. "WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Helminths: Lymphatic filariasis: Diethylcarbamazine".

Adapted from the FDA Package Insert.